← Back to Search

High Resolution Ultasound for Pancreatic Cancer

N/A
Waitlist Available
Led By Korosh Khalili, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 2 weeks of surgery
Awards & highlights

Study Summary

This trial is testing the use of high resolution ultrasound to improve the accuracy of diagnosing pancreatic cancer and determining if it has spread.

Eligible Conditions
  • Pancreatic Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 2 weeks of surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 weeks of surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
High-resolution U/S will be used to measure vascular invasion and regional lymph node metastases in PDAC

Trial Design

1Treatment groups
Experimental Treatment
Group I: High Resolution UltasoundExperimental Treatment1 Intervention
Diagnostic high resolution ultrasound pre-operatively and intraoperatively
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~1950

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,475 Previous Clinical Trials
485,060 Total Patients Enrolled
Korosh Khalili, MDPrincipal InvestigatorUHN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025